[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100556730":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":12,"locations":18,"responsibleParty":34,"collaborators":7,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":52,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"University Medical Center Groningen","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Radiotherapy","Follow-up",[13],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},"Hiske vd Weide","CONTACT","050-3615632","h.l.van.der.weide@umcg.nl",[19],{"facility":20,"status":21,"city":22,"state":7,"zip":23,"country":24,"countryCode":25,"cosmosGeoPoint":26,"geoPoint":31,"contacts":32},"UMCG","RECRUITING","Groningen","9713GZ","Netherlands","NL",{"type":27,"coordinates":28},"Point",[29,30],6.56667,53.21917,{"lat":30,"lon":29},[33],{"name":14,"role":15,"phone":16,"phoneExt":7,"email":17},{"type":35,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100556730","standard-follow-up-program-neuro-oncology-patients-sfp-neuro-oncology-100556730",false,"NCT06528912","Standard Follow-up Program Neuro-oncology Patients (SFP Neuro-Oncology)","Standard Follow-up Program (SFP) for Neuro-oncology Cancer Patients Treated With Radiotherapy","Inclusion Criteria:\n\n* Patient with neuro-oncological cancer\n* Patient receiving a radiotherapy dose XXX Gy\n\nExclusion Criteria:\n\n* Failure to comply with any of the inclusion criteria","ALL","18 Years",{"count":46,"type":47},10000,"ESTIMATED","OBSERVATIONAL","Standardised evaluation of baseline data regarding tumor-, patient- and treatment-characteristics as well as follow-up data regarding tumor- and clinical-outcome of neuro-oncology patients treated with radical\u002Fcurative radiotherapy.\n\nMotive:\n\nCurrently there is limited data on dose-effect relationships of tissues and structures in and around the brain. This lack of knowledge hampers patient selection for proton therapy, technique innovations, and accurate prediction of treatment outcome.\n\nGoal:\n\nTo evaluate the selection for radiation treatment, obtain more knowledge on dose-effect relationships and enable insight in necessary treatment technique innovations that would improve treatment outcome.",[51],"Neurological Cancer",[53,54,55],"Acute toxicity","Late toxicity","Prediction models","2024-07-29",{"date":58,"type":59},"2024-07-30","ACTUAL",{"date":61,"type":59},"2017-12-01",{"date":63,"type":47},"2040-01",{"name":5,"class":6},1]